EcoDrugPlus

Opioid Receptor, Delta 1b

Ensembl ID : ENSEBUG00000003196
Gene Symbol: OPRD1B
1 Cross references
254 Possible Orthologues:

Parathyroid Hormone 1 Receptor

Ensembl ID : ENSEBUG00000011753
Gene Symbol: PTH1R
1 Cross references
198 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Alpha B

Ensembl ID : ENSEBUG00000013738
Gene Symbol: PPARAB
1 Cross references
456 Possible Orthologues:

Peroxisome Proliferator-Activated Receptor Delta B

Ensembl ID : ENSEBUG00000005433
Gene Symbol: PPARDB
1 Cross references
418 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha

Ensembl ID : ENSEBUG00000014799
Gene Symbol: PIK3CA
1 Cross references
196 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Delta

Ensembl ID : ENSEBUG00000013272
Gene Symbol: PIK3CD
1 Cross references
214 Possible Orthologues:

Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Gamma

Ensembl ID : ENSEBUG00000016177
Gene Symbol: PIK3CG
1 Cross references
214 Possible Orthologues:

Phosphodiesterase 10a

Ensembl ID : ENSEBUG00000006303
Gene Symbol: PDE10A
1 Cross references
207 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSEBUG00000007281
Gene Symbol: PDE4B
1 Cross references
302 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSEBUG00000000343
Gene Symbol: PDE7A
1 Cross references
240 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSEBUG00000000859
Gene Symbol: PDE9A
1 Cross references
285 Possible Orthologues:

Phosphoinositide-3-Kinase, Regulatory Subunit 1 (Alpha)

Ensembl ID : ENSEBUG00000013607
Gene Symbol: PIK3R1
1 Cross references
259 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).